13F-HR filed by Avidity Partners Management LP
Avidity Partners Management LP filed this 13F-HR for the quarter ended 2022-09-30, filed 2022-11-14, with 97 holding rows worth $4,918,761,000.
- Accession
- 0001791827-22-000008
- Filer
- CIK 1791827
- Filed
- 2022-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2022
A holdings report, 98 entries on the cover page, a total value of $4,918,761,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $4,918,761,000 with VALUE read as thousands by filing date, 13F file number 028-20028. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Eli Lilly and Company | 532457108 | COM | 1,007,000 | $325,613,000 | thousands by filing date | |
| SPDR SERIES TRUST | 78464A900 | ST STR SP BIOT | 4,052,000 | $321,404,000 | thousands by filing date | call |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 970,200 | $203,140,000 | thousands by filing date | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 1,855,700 | $197,094,000 | thousands by filing date | |
| ARVINAS INC | 04335A105 | COM | 4,343,500 | $193,242,000 | thousands by filing date | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 491,800 | $173,630,000 | thousands by filing date | |
| BIOGEN INC COM | 09062X103 | Stock | 600,000 | $160,200,000 | thousands by filing date | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 512,800 | $148,476,000 | thousands by filing date | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 5,586,900 | $134,253,000 | thousands by filing date | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 1,967,000 | $119,259,000 | thousands by filing date | |
| SPDR SER TR | 78464A870 | S&P BIOTECH | 1,480,000 | $117,394,000 | thousands by filing date | |
| ACADIA HEALTHCARE COMPANY INC COM | 00404A109 | Stock | 1,389,200 | $108,608,000 | thousands by filing date | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 3,122,000 | $106,304,000 | thousands by filing date | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 948,200 | $104,814,000 | thousands by filing date | |
| HUMANA INC COM | 444859102 | Stock | 212,000 | $102,860,000 | thousands by filing date | |
| Boston Scientific Corporation | 101137107 | COM | 2,538,600 | $98,320,000 | thousands by filing date | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 2,079,100 | $97,593,000 | thousands by filing date | |
| KARUNA THERAPEUTICS INC | 48576A100 | COM | 431,800 | $97,125,000 | thousands by filing date | |
| Elevance Health, Inc. | 036752103 | COM | 207,600 | $94,300,000 | thousands by filing date | |
| HORIZON THERAPEUTICS PLC | G46188101 | SHS | 1,482,200 | $91,733,000 | thousands by filing date | |
| ZENTALIS PHARMACEUTICALS INC | 98943L107 | COMMON STOCK | 4,223,100 | $91,472,000 | thousands by filing date | |
| AVANTOR INC COM | 05352A100 | Stock | 4,522,600 | $88,643,000 | thousands by filing date | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 2,051,600 | $84,957,000 | thousands by filing date | |
| NATERA INC COM | 632307104 | Stock | 1,735,000 | $76,028,000 | thousands by filing date | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 1,538,600 | $68,652,000 | thousands by filing date | |
| CATALENT INC USD 0.01 | 148806102 | COM | 940,000 | $68,018,000 | thousands by filing date | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 1,402,500 | $65,258,000 | thousands by filing date | |
| SEAGEN INC | 81181C104 | COM | 445,500 | $60,958,000 | thousands by filing date | |
| BIO RAD LABS INC | 090572207 | CL A | 144,800 | $60,402,000 | thousands by filing date | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 288,500 | $57,746,000 | thousands by filing date | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 844,000 | $57,645,000 | thousands by filing date | |
| INTELLIA THERAPEUTICS INC | 45826J105 | COM | 999,100 | $55,910,000 | thousands by filing date | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 3,715,400 | $55,434,000 | thousands by filing date | |
| KEZAR LIFE SCIENCES INC | 49372L100 | COM | 5,414,400 | $46,618,000 | thousands by filing date | |
| BELLUS HEALTH INC NEW | 07987C204 | COM | 4,346,700 | $45,901,000 | thousands by filing date | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 2,321,200 | $45,774,000 | thousands by filing date | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 2,600,000 | $42,458,000 | thousands by filing date | |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 318,300 | $42,426,000 | thousands by filing date | |
| ZAI LAB LTD ADR | 98887Q104 | ADR | 1,234,000 | $42,203,000 | thousands by filing date | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 1,255,374 | $41,490,000 | thousands by filing date | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 1,981,100 | $41,385,000 | thousands by filing date | |
| DEXCOM INC COM | 252131107 | Stock | 467,600 | $37,661,000 | thousands by filing date | |
| Stryker Corporation | 863667101 | COM | 184,700 | $37,409,000 | thousands by filing date | |
| VERVE THERAPEUTICS INC | 92539P101 | COM | 1,042,706 | $35,817,000 | thousands by filing date | |
| ALTIMMUNE INC | 02155H200 | COM NEW | 2,684,000 | $34,275,000 | thousands by filing date | |
| CENTENE CORP DEL COM | 15135B101 | Stock | 432,400 | $33,645,000 | thousands by filing date | |
| CARIBOU BIOSCIENCES INC COM | 142038108 | Stock | 3,172,600 | $33,471,000 | thousands by filing date | |
| ASTRAZENECA PLC SPONSORED ADR | 046353108 | ADR | 563,200 | $30,886,000 | thousands by filing date | |
| NGM BIOPHARMACEUTICALS INC | 62921N105 | COM | 1,798,100 | $23,519,000 | thousands by filing date | |
| DECIPHERA PHARMACEUTICALS IN | 24344T101 | COM | 1,191,800 | $22,048,000 | thousands by filing date | |
| POINT BIOPHARMA GLOBAL INC | 730541109 | COM | 2,820,000 | $21,799,000 | thousands by filing date | |
| PHATHOM PHARMACEUTICALS INC | 71722W107 | COMMON STOCK | 1,906,800 | $21,127,000 | thousands by filing date | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 1,357,700 | $20,257,000 | thousands by filing date | |
| NKARTA INC | 65487U108 | COMMON STOCK | 1,414,082 | $18,609,000 | thousands by filing date | |
| BEONE MEDICINES LTD SPONSORED ADS | 07725L102 | ADR | 132,000 | $17,796,000 | thousands by filing date | |
| SI BONE INC | 825704109 | COM | 996,700 | $17,402,000 | thousands by filing date | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 1,450,000 | $17,371,000 | thousands by filing date | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 335,000 | $16,231,000 | thousands by filing date | |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 794,500 | $15,183,000 | thousands by filing date | |
| VAXCYTE INC COM | 92243G108 | Stock | 628,700 | $15,089,000 | thousands by filing date | |
| ALPHATEC HLDGS INC | 02081G201 | COM NEW | 1,715,000 | $14,989,000 | thousands by filing date | |
| KINNATE BIOPHARMA INC | 49705R105 | COM | 1,212,611 | $14,491,000 | thousands by filing date | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 1,382,900 | $13,248,000 | thousands by filing date | |
| AN2 THERAPEUTICS INC | 037326105 | COM | 742,630 | $12,907,000 | thousands by filing date | |
| CENTURY THERAPEUTICS INC | 15673T100 | COM | 1,303,600 | $12,893,000 | thousands by filing date | |
| TRANSMEDICS GROUP INC | 89377M109 | COM | 300,000 | $12,522,000 | thousands by filing date | |
| SANGAMO THERAPEUTICS INC | 800677106 | COM | 2,360,800 | $11,568,000 | thousands by filing date | |
| STOKE THERAPEUTICS INC | 86150R107 | COM | 891,100 | $11,442,000 | thousands by filing date | |
| SEASPINE HLDGS CORP | 81255T108 | COM | 2,010,000 | $11,417,000 | thousands by filing date | |
| NANOSTRING TECHNOLOGIES INC | 63009R109 | COM | 698,200 | $8,916,000 | thousands by filing date | |
| ERASCA INC COM | 29479A108 | Stock | 982,500 | $7,664,000 | thousands by filing date | |
| ALPINE IMMUNE SCIENCES INC | 02083G100 | COM | 998,600 | $7,190,000 | thousands by filing date | |
| SURGERY PARTNERS INC | 86881A100 | COM | 267,600 | $6,262,000 | thousands by filing date | |
| SYROS PHARMACEUTICALS INC | 87184Q206 | COM NEW | 900,000 | $5,796,000 | thousands by filing date | |
| CAREMAX INC | 14171W103 | COM | 755,329 | $5,355,000 | thousands by filing date | |
| MEDICUS SCIENCES ACQUISITION | G5960S108 | CL A SHS | 520,000 | $5,148,000 | thousands by filing date | |
| BCLS ACQUISITION CORP | G0904B105 | CMN | 500,000 | $5,010,000 | thousands by filing date | |
| GRAPHITE BIO INC | 38870X104 | COM | 1,575,000 | $4,993,000 | thousands by filing date | |
| ARYA SCIENCES ACQU CORP IV | G31659108 | COM | 500,000 | $4,955,000 | thousands by filing date | |
| PANACEA ACQUISITION CORP II | G6882C106 | COM | 500,000 | $4,900,000 | thousands by filing date | |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 2,000,000 | $4,560,000 | thousands by filing date | |
| ESSA PHARMA INC | 29668H708 | COM NEW | 2,460,000 | $4,477,000 | thousands by filing date | |
| HEALTH SCIENCES ACQ CORP 2 | G4411D109 | ORD SHS | 400,000 | $3,960,000 | thousands by filing date | |
| CYTEIR THERAPEUTICS INC | 23284P103 | COMMON | 1,806,200 | $3,468,000 | thousands by filing date | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 813,700 | $2,946,000 | thousands by filing date | |
| SCYNEXIS INC | 811292200 | COM NEW | 1,140,600 | $2,737,000 | thousands by filing date | |
| SOCIAL CAP SUVRETTA HLDS CP | G8253Y105 | CLASS A ORD SHS | 200,000 | $1,964,000 | thousands by filing date | |
| SOCIAL CAP SUVRETTA HLDS CRP | G8253U103 | CMN | 200,000 | $1,960,000 | thousands by filing date | |
| ONCOSEC MED INC | 68234L306 | COM | 2,945,000 | $1,437,000 | thousands by filing date | |
| HYPERFINE INC | 44916K106 | Common Stock | 1,503,754 | $1,218,000 | thousands by filing date | |
| AC IMMUNE SA | H00263105 | SHS | 274,876 | $869,000 | thousands by filing date | |
| REUNION NEUROSCIENCE INC | 76134G103 | COM | 595,200 | $851,000 | thousands by filing date | |
| SEMA4 HOLDINGS CORP | 81663L101 | COM | 950,000 | $834,000 | thousands by filing date | |
| PHASEBIO PHARMACEUTICALS INC | 717224109 | COM | 4,361,365 | $768,000 | thousands by filing date | |
| SCIENCE 37 HOLDINGS INC | 808644108 | COM | 430,000 | $692,000 | thousands by filing date | |
| NUVATION BIO INC | 67080N119 | WARR | 99,999 | $18,000 | thousands by filing date | |
| MEDICUS SCIENCES ACQUISITION | G5960S124 | *W EXP 02/12/202 | 57,770 | $1,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001791827-22-000008 | this filing | 2022-11-14 | acceptance time not in the bulk data set |